Warfarin or novel oral anticoagulants for atrial fibrillation?

Affiliations

¹ Department of Cardiology, Aalborg AF Study Group, Aalborg University Hospital, Aalborg DK-9000, Denmark; Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Faculty of Health, Aalborg University, Aalborg, Denmark. Electronic address: tobl@rn.dk.
² Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Faculty of Health, Aalborg University, Aalborg, Denmark; Centre for Cardiovascular Sciences, University of Birmingham, City Hospital, Birmingham, UK.

Comment

Torben Bjerregaard Larsen et al. Lancet. 2014.

. 2014 Mar 15;383(9921):931-3.

doi: 10.1016/S0140-6736(13)62376-4. Epub 2013 Dec 4.

¹ Department of Cardiology, Aalborg AF Study Group, Aalborg University Hospital, Aalborg DK-9000, Denmark; Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Faculty of Health, Aalborg University, Aalborg, Denmark. Electronic address: tobl@rn.dk.
² Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Faculty of Health, Aalborg University, Aalborg, Denmark; Centre for Cardiovascular Sciences, University of Birmingham, City Hospital, Birmingham, UK.

No abstract available

Comment on

Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials.
Ruff CT, Giugliano RP, Braunwald E, Hoffman EB, Deenadayalu N, Ezekowitz MD, Camm AJ, Weitz JI, Lewis BS, Parkhomenko A, Yamashita T, Antman EM. Ruff CT, et al. Lancet. 2014 Mar 15;383(9921):955-62. doi: 10.1016/S0140-6736(13)62343-0. Epub 2013 Dec 4. Lancet. 2014. PMID: 24315724